Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 158

1.

Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease.

Fernando R, Grisolia ABD, Lu Y, Atkins S, Smith TJ.

J Immunol. 2018 Jun 15;200(12):3942-3949. doi: 10.4049/jimmunol.1800259. Epub 2018 May 11.

2.

Promoter hypermethylation of SLIT2 is a risk factor and potential diagnostic biomarker for nasopharyngeal carcinoma.

Li J, Zhou C, Wang G, Wang S, Ni S, Ye M, Zhang J.

Gene. 2018 Feb 20;644:74-79. doi: 10.1016/j.gene.2017.10.059. Epub 2017 Nov 8.

PMID:
29107007
3.

The differential roles of Slit2-exon 15 splicing variants in angiogenesis and HUVEC permeability.

Yang YC, Chen PN, Wang SY, Liao CY, Lin YY, Sun SR, Chiu CL, Hsieh YS, Shieh JC, Chang JT.

Angiogenesis. 2015 Jul;18(3):301-12. doi: 10.1007/s10456-015-9467-4. Epub 2015 May 29.

PMID:
26021305
4.

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.

Secq V, Leca J, Bressy C, Guillaumond F, Skrobuk P, Nigri J, Lac S, Lavaut MN, Bui TT, Thakur AK, Callizot N, Steinschneider R, Berthezene P, Dusetti N, Ouaissi M, Moutardier V, Calvo E, Bousquet C, Garcia S, Bidaut G, Vasseur S, Iovanna JL, Tomasini R.

Cell Death Dis. 2015 Jan 15;6:e1592. doi: 10.1038/cddis.2014.557.

5.

Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis.

Pilling D, Zheng Z, Vakil V, Gomer RH.

Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):18291-6. doi: 10.1073/pnas.1417426112. Epub 2014 Dec 8.

6.

Slit2 exerts anti-inflammatory actions in human placenta and is decreased with maternal obesity.

Lim R, Lappas M.

Am J Reprod Immunol. 2015 Jan;73(1):66-78. doi: 10.1111/aji.12334. Epub 2014 Oct 20.

PMID:
25329354
7.

Slit2 is decreased after spontaneous labour in myometrium and regulates pro-labour mediators.

Lim R, Liong S, Barker G, Lappas M.

J Reprod Immunol. 2014 Dec;106:76-88. doi: 10.1016/j.jri.2014.07.001. Epub 2014 Jul 27.

PMID:
25130654
8.

Increased permeability of the blood-brain barrier and Alzheimer's disease-like alterations in slit-2 transgenic mice.

Li JC, Han L, Wen YX, Yang YX, Li S, Li XS, Zhao CJ, Wang TY, Chen H, Liu Y, Qi CL, He XD, Gu QL, Ye YX, Zhang Y, Huang R, Wu YE, He RR, Kurihara H, Song XY, Cao L, Wang LJ.

J Alzheimers Dis. 2015;43(2):535-48. doi: 10.3233/JAD-141215.

PMID:
25114073
9.

Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.

Göhrig A, Detjen KM, Hilfenhaus G, Körner JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B, Fischer C.

Cancer Res. 2014 Mar 1;74(5):1529-40. doi: 10.1158/0008-5472.CAN-13-1012. Epub 2014 Jan 21.

10.

Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.

Shi R, Yang Z, Liu W, Liu B, Xu Z, Zhang Z.

Oncol Rep. 2014 Feb;31(2):812-8. doi: 10.3892/or.2013.2887. Epub 2013 Dec 2.

PMID:
24297051
11.

Reduced expression of Slit2 in renal cell carcinoma.

Ma WJ, Zhou Y, Lu D, Dong D, Tian XJ, Wen JX, Zhang J.

Med Oncol. 2014 Jan;31(1):768. doi: 10.1007/s12032-013-0768-4. Epub 2013 Nov 15.

PMID:
24287947
12.

Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer.

Shi R, Liu W, Liu B, Xu Z, Chen L, Zhang Z.

Oncol Rep. 2013 Oct;30(4):1883-9. doi: 10.3892/or.2013.2662. Epub 2013 Aug 7.

PMID:
23933755
13.

Loss of expression and promoter methylation of SLIT2 are associated with sessile serrated adenoma formation.

Beggs AD, Jones A, Shepherd N, Arnaout A, Finlayson C, Abulafi AM, Morton DG, Matthews GM, Hodgson SV, Tomlinson IP.

PLoS Genet. 2013 May;9(5):e1003488. doi: 10.1371/journal.pgen.1003488. Epub 2013 May 9.

14.

Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis.

Guo SW, Zheng Y, Lu Y, Liu X, Geng JG.

Reprod Sci. 2013 Mar;20(3):285-98. doi: 10.1177/1933719112452940. Epub 2012 Aug 8.

15.

Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer.

Dong R, Yu J, Pu H, Zhang Z, Xu X.

J Int Med Res. 2012;40(2):681-6.

PMID:
22613430
16.

The axonal repellent Slit2 inhibits pericyte migration: potential implications in angiogenesis.

Guijarro-Muñoz I, Cuesta AM, Alvarez-Cienfuegos A, Geng JG, Alvarez-Vallina L, Sanz L.

Exp Cell Res. 2012 Feb 15;318(4):371-8. doi: 10.1016/j.yexcr.2011.12.005. Epub 2011 Dec 14.

PMID:
22198087
17.

Detection of Slit2 promoter hypermethylation in tissue and serum samples from breast cancer patients.

Kim GE, Lee KH, Choi YD, Lee JS, Lee JH, Nam JH, Choi C, Park MH, Yoon JH.

Virchows Arch. 2011 Oct;459(4):383-90. doi: 10.1007/s00428-011-1143-5. Epub 2011 Sep 6.

PMID:
21894562
18.

SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated.

Qiu H, Zhu J, Yu J, Pu H, Dong R.

Asian Pac J Cancer Prev. 2011;12(3):791-5.

19.

A novel exon 15-deleted, splicing variant of Slit2 shows potential for growth inhibition in addition to invasion inhibition in lung cancer.

Lin YY, Yang CH, Sheu GT, Huang CY, Wu YC, Chuang SM, Fann MJ, Chang H, Lee H, Chang JT.

Cancer. 2011 Aug 1;117(15):3404-15. doi: 10.1002/cncr.25890. Epub 2011 Jan 24.

20.

Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity.

Yiin JJ, Hu B, Jarzynka MJ, Feng H, Liu KW, Wu JY, Ma HI, Cheng SY.

Neuro Oncol. 2009 Dec;11(6):779-89. doi: 10.1215/15228517-2008-017.

Supplemental Content

Support Center